Bridging the Gap Between End-to-End Supply Chain Strategy and Successful Implementation

08:30 Networking and refreshments Networking and Refreshments

09:00 Chairman's day two opening and recap of key themes from day 1 Chairman's day two opening and recap of key themes from day 1

09:15 Keynote Market Analysis: The capital markets’ perspective on the pharma industry and the impacts of M&A activity Andrew Baum, Managing Director and Head of Pharmaceuticals & Healthcare Research, Citi Short, medium and long term forecasts Industry consolidation appraisal to date: Can we expect the wave of M&A to continue? Impact on stock pricing and valuations Are pharma mega-mergers truly delivering shareholder value? Andrew Baum Managing Director and Head of Pharmaceuticals & Healthcare Research, Citi Andrew joined Citi in September 2011, as the Global Head of Healthcare Research. He benefits from a deep strategic insight of the global healthcare value chain, as well as broad network of contacts throughout the industry. In 2004, Andrew was one of the earliest commentators to highlight to investors the deep structural deficiencies of the historic operating structure and the need to evolve toward [read more]

10:00 Panel Discussion: Driving efficiencies and synergies from a post M&A supply chain integration Danny Hendrikse, Vice President EMEA Supply Chain Operations, Pfizer Giulio Amore, Head of Supply Chain Process Management, Abbott Theodore Iliopoulos, Polpharma The major issues being faced Establishing a single face in front of the customer as soon as possible ERP integration across wide geographies – deciding on the appropriate system for tomorrow’s supply chain Designing processes around the system and not system around the processes Overcoming system limitations The role of advanced planning systems to facilitate integration and interoperability Establishing a harmonised outsourcing to fit the strategy Challenges in integrating biotech with ethical pharma Avoiding the common mistakes and politicisation Measuring value and demonstrating synergies to the board Danny Hendrikse Vice President EMEA Supply Chain Operations, Pfizer Giulio Amore Head of Supply Chain Process Management, Abbott Theodore Iliopoulos , Polpharma

Morning refreshments and networkingSpeaker's corner 10.45 Morning refreshments and networking Morning refreshments and networking Morning refreshments and networking 10:45 Speaker's corner Speaker's corner During the break, visit an area of the event dedicated to interaction with the previous session’s speakers and panellists. This is your opportunity to network and speak openly about any questions not covered during their session.

11:15 Plenary: Integrated business planning for tomorrow's supply chain organisational requirements - looking beyond the long horizon to functionally integrate decision making - Hosted by Lodestone Management Consultants: Jacques Le Ny, Partner, Lodestone Management Consultants Integrating multiple functions into the decision making process Going beyond S&OP Jacques Le Ny Partner, Lodestone Management Consultants Jacques’s is specialized in supply chain planning & collaboration. He holds a master degree in information processing and started his career during 5 years in the high tech industry as a qualified electronics engineer before becoming a consultant specialized in manufacturing, just-in-time and logistics. He then focused on supply chain planning with various technologies, Numetrix, M [read more]

12.00 Investigating the challenges facing supply chain organisations in pharma Julian Amey, Principal Fellow, Warwick University Findings from a study of supply chain organisations across  different process industry sectors: chemicals, Pharma and FMCG Key challenges facing the supply chain and how different supply chain organisations are responding The development and maturity of supply chain organisations How different organisations are handling globalisation Leadership in the supply chain Julian Amey Principal Fellow, Warwick University Julian Amey is a Principal Fellow at Warwick University with advisory responsibilities for supply chain and operations management. Julian joined ICI in 1978 as a Control Engineer after studying General Engineering at University followed by postgraduate Production Management. After roles in project engineering, maintenance engineering and production management, he was seconded to ICI Pharmaceutical [read more]

Networking LuncheonSpeaker's corner Networking Luncheon Networking Luncheon Networking Luncheon Speaker's corner Speaker's corner Speaker's corner

Challenging temperature controlled supply chain paradigm...Emerging channel management strategies and regional appr... 14.00 Panel discussion: The world has moved on, why hasn’t cold chain? Challenging cold chain freight paradigms Challenging temperature controlled supply chain paradigms and the shifting regulatory environment Martin Olmedo, Head of Logistics, Roche Stuart Dickson, Head of Global Supply Chain (Vaccines), Novartis Yoram Eshel, Senior Director, Global Shipping and Logistics, Teva Evaluating options for effective temperature control and validation The challenges being faced Active cooling solutions The distribution chain beyond your control Compliance, validation and collaboration Pushing a duty of care agenda Ensuring compliance in remote area The solutions Capitalising on technology advancements Making it easier for partners to operate and maintain compliance Moving from a technology compliance programme to a people programme Cold chain strategies for emerging markets Tailoring your process Customising packaging How can we, as supply chain leaders, drive positive change in this area? Martin Olmedo Head of Logistics, Roche Stuart Dickson Head of Global Supply Chain (Vaccines), Novartis After nearly 20 years with GlaxoSmithKline covering a wide variety of technical, production and supply chain roles, Stuart joined Novartis Vaccines 4 years ago as Head of Supply Chain. Since then his role has expanded to include responsibility for systems and business processes associated with Supply Chain. In his current role, Stuart is accountable for all planning, warehousing, artwork and cold [read more] Yoram Eshel Senior Director, Global Shipping and Logistics, Teva Yoram has an MBA in Economics and Business Administration. He has vast experience in global transportation systems and processes including all modes of transportation, Forwarding, Customs compliance programs, GDP and temperature management, Security, Safety and Environment implications. Yoram has specialized in the Pharma and API industries including clinical trials, medical devices and bio pharma [read more] 14.00 Panel discussion: Addressing the downstream value model and changes in channel management strategy necessary to compete effectively in tomorrow’s healthcare environment Emerging channel management strategies and regional approaches to maximise business growth in both established and growth markets Christoph Feldmann, Senior Director - Supply Chain Leader Alliance, Pfizer Philippe Francois, VP, Supply Chain EMEA, Baxter Healthcare The decline of the blockbuster model and impacts on future operations Defining a differentiated channel approach: Value added Increasing compliance and transparency Ensuring market access Portfolio segmentation best practices Impacts on service level Driving cost efficiencies and service level increases Established vs. patented considerations The evolution of direct to pharmacy and patient No longer just for high value, low volume products Getting closer to the customer to drive a competitive advantage Sharing infrastructure to reduce costs Going it alone vs. with an LSP Christoph Feldmann Senior Director - Supply Chain Leader Alliance, Pfizer Christoph is responsible for the strategic business support, the strategic planning and the strategic projects within logistics, distribution and supply for all Pfizer businesses in Europe, the Middle East and Africa. An important part of his role is the EMEA-wide coordination of the conception, planning and implementation of innovative distribution models and network concepts, such as new distrib [read more] Philippe Francois VP, Supply Chain EMEA, Baxter Healthcare Philippe Francois is currently the Supply Chain vice president for Baxter healthcare for the Europe Middle East and Africa region He holds a master degree in engineering and an MBA and started his career in the automotive industry in France where he acquired a solid experience in Just in time techniques. He joined the healthcare industry where he has been working for the last 15 years and acquire [read more]

Challenging temperature controlled supply chain paradigm...Emerging channel management strategies and regional appr... 14.30 Interactive breakout session led by DHL on EU Regulatory updates and strategies: How the regulatory environment is shifting and the key information you need to keep ahead of these changes Challenging temperature controlled supply chain paradigms and the shifting regulatory environment Mike Meakin, VP - Global Quality Regulatory & Compliance, Life Sciences & Healthcare, DHL The new directives and GDP requirements: what they mean to you and how long do you have left to comply? What needs to be done? Enforcing temperature monitoring rather than just qualification Process changes EU changes vs. requirements in growth markets and how regulations are set to evolve Mike Meakin VP - Global Quality Regulatory & Compliance, Life Sciences & Healthcare, DHL Mike Meakin has over 30 years experience in logistics working around the world. His last 20 years experience has been within highly regulated Pharmaceuticals, and Chemical supply chains; including wholesale operations. Mike has spent the over 10 years with DHL & Exel previously focused in Life Science and Healthcare industry sector covering biologics, medical devices and pharmaceut [read more] 14.30 Keynote: Setting up distribution models to maximize reach in sub-Saharan Africa Emerging channel management strategies and regional approaches to maximise business growth in both established and growth markets Prashant Yadav, Senior Research Fellow and Director of the Healthcare Research Initiative, William Davidson Institute, University of Michigan Supply chain network design and supply chain strategy for sub-Saharan Africa Adopting a multi-layered approach Tiered and differential pricing In-country operational experts and global project coordination Dealing with the supply/demand mismatch The fundamental changes required in operations and incentives Leveraging innovative but frugal technology for optimizing your supply chain in sub-Saharan Africa How can we, as pharma supply chain thought leaders, help improve access to essential medicines while maintaining business growth and sustainability? Prashant Yadav Senior Research Fellow and Director of the Healthcare Research Initiative, William Davidson Institute, University of Michigan Prashant Yadav is a Senior Research Fellow and Director of the Health Care Research Initiative at the William Davidson Institute (WDI) at the University of Michigan. He also is on the faculty at the Ross School of Business and the School of Public Health at the University of Michigan. A leading expert on pharmaceutical and healthcare supply chains in developing countries, Dr. Yadav research explor [read more]

Afternoon coffeeSpeaker's Corner 15.00 Afternoon coffee Afternoon coffee Afternoon coffee 15:00 Speaker's Corner Speaker's Corner Speaker's Corner

The extended supply chain – outsourcing approaches and b...Leveraging supply chain sustainability for bottom-line g... 15.30 Case study: Consolidating a pan-European distribution network – getting ready for growth of product portfolio and volumes The extended supply chain – outsourcing approaches and best-of-breed strategies for success Frank Binder, Senior Director International Logistics & Supply Chain, Celgene Transforming our distribution network from an Agile to an Efficient Supply Chain to better support future business needs Looking beyond the Supply Chain: Quality, M&S, Regulatory and Finance business needs influencing the Supply Chain design Changing role of the Logistics Service Provider as consequence of the Supply Chain transformation Managing the Supply Chain design and LSP selection, to find the best solutions while ensuring internal buy-in Linking IT systems and aligning business processes to ensure transparency and visibility for both sides Building the right relationships and governance to achieve joint success of pharma company and its LSP Frank Binder Senior Director International Logistics & Supply Chain, Celgene Frank Binder is Director, International Logistics and Supply Chain, at Celgene, based in Switzerland. Currently his main task is expanding and managing Celgene’s international pharmaceutical logistics setup, optimizing the European distribution network while building a new distribution network across Asia. He is guided by his team’s mission statement : “Products to the Patients – Every Time, On Ti [read more] 15.30 Case study: Horizontal collaboration: Bringing together overlapping transport lanes to drive efficiency and customer service levels Leveraging supply chain sustainability for bottom-line growth Ludovic Menedeme, Director Transport EMEA, Baxter A question of chemistry – determining compatibility and potential costs savings Combating the added complexity Utilising cloud solutions to sidestep data compatibility and interoperability issues Passing anti-trust and anti-competitiveness hurdles Collaboration in new and emerging markets Tangible benefits delivered Service levels Delivery times CO2 emissions and supply chain sustainability Cost savings and break-even times Supply chain synchronisation Collaboration as tool to bring about immediate increases in supply chain visibility and uncovering new areas of optimisation How collaboration is set to evolve in the near future Ludovic Menedeme Director Transport EMEA, Baxter Initially graduated as engineer in electro-mechanics and holding an MBA in industrial management, Ludovic joined Baxter in 1995 and since then he has fulfilled several roles within the Supply Chain organization.He has experience in the production area, planning & deployment, demand & forecasting, European and ECEMEA inventory management.From 2001, he is managing the [read more]

The extended supply chain – outsourcing approaches and b...Leveraging supply chain sustainability for bottom-line g... 16.00 Case Study: The challenges of engineering an effective supply chain model in an Orphan Drug environment: Achieving a “win-win” LSP relationship The extended supply chain – outsourcing approaches and best-of-breed strategies for success Mairéad Plekkenpol, Director Supply Chain EMEA, Shire Pharmaceuticals The unique Orphan Drug classification considerations and need for a complete supply chain re-design Navigating the considerable compliance issues Optimising 3rd party material flow and the facilities required Integrating late stage differentiation into the supply chain The next step: optimising distribution Mairéad Plekkenpol Director Supply Chain EMEA, Shire Pharmaceuticals 16.00 Focus on the bottom line: Sustainability as a driver for cost efficiencies, risk mitigation and enhanced service levels Leveraging supply chain sustainability for bottom-line growth Evidence assessment - is it worth being green? Can a lean inventory management drive sustainable resource consumption? Postponement, standardisation and late differentiations to drive savings Staying close to the customer The technologies and innovation driving supply chain flexibility and agility Maintaining compliance whilst becoming more efficient

Chairperson's closing remarks, followed by close of conf...Speaker's corner 16.30 Chairperson's closing remarks, followed by close of conference Chairperson's closing remarks, followed by close of conference Chairperson's closing remarks, followed by close of conference 16:30 Speaker's corner Speaker's corner Speaker's corner